DICE Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2021 to Q2 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
DICE Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2021 to Q2 2023.
  • DICE Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 31, 2023 was 47.8M shares, a 25.1% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 47.8M +9.58M +25.1% Jul 31, 2023 10-Q 2023-08-08
Q1 2023 47.7M +9.48M +24.8% Mar 8, 2023 10-K 2023-03-15
Q3 2022 47.7M +9.44M +24.7% Oct 31, 2022 10-Q 2022-11-09
Q2 2022 38.2M Aug 1, 2022 10-Q 2022-08-11
Q1 2022 38.2M Mar 15, 2022 10-K 2022-03-28
Q3 2021 38.2M Oct 31, 2021 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.